이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Electromed 관리

관리 기준 확인 1/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Jim Cunniff

최고 경영자

n/a

총 보상

CEO 급여 비율	n/a
CEO 임기	less than a year
CEO 소유권	0.1%
경영진 평균 재임 기간	데이터 없음
이사회 평균 재임 기간	4.9yrs

최근 관리 업데이트

Recent updates

What Percentage Of Electromed, Inc. (NYSEMKT:ELMD) Shares Do Insiders Own?

Mar 07

Is Electromed, Inc.'s (NYSEMKT:ELMD) Latest Stock Performance A Reflection Of Its Financial Health?

Feb 17

Electromed, Inc.'s (NYSEMKT:ELMD) Intrinsic Value Is Potentially 90% Above Its Share Price

Dec 16

Announcing: Electromed (NYSEMKT:ELMD) Stock Soared An Exciting 405% In The Last Five Years

Dec 04

How Is Electromed's (NYSEMKT:ELMD) CEO Paid Relative To Peers?

Nov 22

CEO

Jim Cunniff (58 yo)

less than a year

테뉴어

Mr. James L. Cunniff, also known as Jim, serves as the President and Chief Executive Officer at Electromed, Inc., since July 01, 2023 and serves as its Director since November 10, 2023. He is Operating Par...

이사회 구성원

이름	위치	테뉴어	보상	소유권
James Cunniff	President	less than a year	데이터 없음	0.12% $ 150.3k
Gregory Fluet	Independent Director	4.9yrs	US$78.58k	0.17% $ 225.5k
Kathleen Skarvan	Chairman	10.7yrs	US$1.08m	2.67% $ 3.5m
Andrew Summers	Independent Director	2yrs	US$68.58k	0.035% $ 45.1k
Kathleen Tune	Independent Director	2.7yrs	US$76.58k	0.10% $ 135.3k
Andrea Walsh	Independent Director	3.7yrs	US$75.33k	0.14% $ 180.4k
Stan Erickson	Independent Vice Chairman of the Board	9.7yrs	US$81.58k	0.38% $ 493.2k
Joseph Galatowitsch	Independent Director	2.7yrs	US$71.58k	0.10% $ 135.3k
Anne O'Donnell	Member of Bronchiectasis Advisory Board	6.9yrs	데이터 없음	데이터 없음
Chad Marion	Member of Bronchiectasis Advisory Board	6.9yrs	데이터 없음	데이터 없음
Peadar Noone	Member of Bronchiectasis Advisory Board	6.9yrs	데이터 없음	데이터 없음

4.9yrs

평균 재임 기간

59.5yo

평균 연령

경험이 풍부한 이사회: ELMD 의 이사회는 경험(평균 재직 기간 4.8 년)으로 간주됩니다.

Electromed 관리

관리 기준 확인 1/4

주요 정보

최근 관리 업데이트

President recently bought US$137k worth of stock

Electromed, Inc., Annual General Meeting, Nov 10, 2023

Electromed, Inc. Announces Appointment of Jim Cunniff as Its New President and Board of Director, Effective July 1, 2023

CEO, President & Director exercised options and sold US$245k worth of stock

Electromed, Inc. Announces Retirement of Kathleen Skarvan as Chief Executive Officer, Effective on or Around July 1, 2023

Electromed, Inc. Appoints Brad Nagel as Chief Financial Officer, Effective November 14, 2022

Recent updates

Investor sentiment deteriorates as stock falls 17%

Third quarter 2024 earnings: EPS exceeds analyst expectations

New minor risk - Share price stability

Electromed, Inc. to Report Q3, 2024 Results on May 07, 2024

Investor sentiment improves as stock rises 16%

President recently bought US$137k worth of stock

Investor sentiment improves as stock rises 48%

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

Electromed, Inc. to Report Q2, 2024 Results on Feb 13, 2024

First quarter 2024 earnings: EPS and revenues miss analyst expectations

Electromed, Inc. Announces Launch of SmartVest Clearway Airway Clearance System

Electromed, Inc. to Report Q1, 2024 Results on Nov 07, 2023

Electromed, Inc., Annual General Meeting, Nov 10, 2023

Consensus EPS estimates fall by 25%, revenue upgraded

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Electromed, Inc. to Report Q4, 2023 Results on Aug 22, 2023

Electromed, Inc. Announces Appointment of Jim Cunniff as Its New President and Board of Director, Effective July 1, 2023

Third quarter 2023 earnings: EPS exceeds analyst expectations

CEO, President & Director exercised options and sold US$245k worth of stock

Investor sentiment improves as stock rises 15%

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

Electromed, Inc. Announces Retirement of Kathleen Skarvan as Chief Executive Officer, Effective on or Around July 1, 2023

Electromed, Inc. to Report Q2, 2023 Results on Feb 14, 2023

Electromed, Inc. Announces U.S. Food and Drug Administration 510(K) Clearance of Fifth Generation Hfcwo Airway Clearance Generator

Price target increased to US$16.75

First quarter 2023 earnings: EPS misses analyst expectations

Electromed, Inc. to Report Q1, 2023 Results on Nov 08, 2022

Electromed, Inc. Appoints Brad Nagel as Chief Financial Officer, Effective November 14, 2022

Electromed, Inc., Annual General Meeting, Nov 11, 2022

CEO, President & Director exercised options and sold US$59k worth of stock

Investor sentiment improved over the past week

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Electromed, Inc. to Report Q4, 2022 Results on Aug 23, 2022

High number of new directors

Electromed, Inc. Announces Election of Andrew Summers as Additional Independent Director

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

Electromed, Inc. Announces Executive Changes

Electromed, Inc. to Report Q3, 2022 Results on May 10, 2022

Consensus forecasts updated

Second quarter 2022 earnings: EPS and revenues exceed analyst expectations

First quarter 2022 earnings released: EPS US$0.051 (vs US$0.063 in 1Q 2021)

Investor sentiment improved over the past week

Full year 2021 earnings released: EPS US$0.28 (vs US$0.49 in FY 2020)

Electromed, Inc. Provides Preliminary Unaudited Earnings Guidance for the Fourth Quarter Ended June 30, 2021

Summers Value Fund Engages in Discussion with Electromed Shareholders

Electromed, Inc.(NYSEAM:ELMD) dropped from Russell 3000 Growth Index

Electromed, Inc. (NYSEAM:ELMD) announces an Equity Buyback for $3 million worth of its shares.

Consensus forecasts updated

Third quarter 2021 earnings released: EPS US$0.026 (vs US$0.078 in 3Q 2020)

Price target increased to US$18.00

What Percentage Of Electromed, Inc. (NYSEMKT:ELMD) Shares Do Insiders Own?

Is Electromed, Inc.'s (NYSEMKT:ELMD) Latest Stock Performance A Reflection Of Its Financial Health?

Analysts increase EPS estimates to US$0.34

Revenue and earnings beat expectations

Second quarter 2021 earnings released: EPS US$0.14 (vs US$0.14 in 2Q 2020)

New 90-day high: US$10.76

Should You Be Impressed By Electromed's (NYSEMKT:ELMD) Returns on Capital?

Electromed, Inc. to Report Q2, 2021 Results on Feb 09, 2021

Did Electromed, Inc. (NYSEMKT:ELMD) Insiders Sell Shares?

Electromed (NYSEMKT:ELMD) Is Growing Earnings But Are They A Good Guide?

New 90-day high: US$10.40

Here's Why I Think Electromed (NYSEMKT:ELMD) Might Deserve Your Attention Today

Electromed, Inc.'s (NYSEMKT:ELMD) Intrinsic Value Is Potentially 90% Above Its Share Price

Announcing: Electromed (NYSEMKT:ELMD) Stock Soared An Exciting 405% In The Last Five Years

How Is Electromed's (NYSEMKT:ELMD) CEO Paid Relative To Peers?

Electromed, Inc. Names Andrea M. Walsh to Serve as an Additional Director

First quarter 2021 earnings released: EPS US$0.063

Revenue and earnings beat expectations

New 90-day low: US$8.60